2 Amendments of Corinne LEPAGE related to 2012/2190(DEC)
Amendment 3 #
Draft opinion
Paragraph 2
Paragraph 2
2. Thinks it is noteworthy in this context that the special report on Conflict of Interests by the Court of Auditors concluded that none of the agencies scrutinised, including the EMA, dealt properly with conflicts of interest; notes that the report is not taking into account to the full the latest developments and improvements put in place by the Agency; therefore, notes with satisfaction the improvement of all procedures related to transparency and possible conflicts of interest in the Agency; intends to ascertain that those procedures are in fact being implemented, especially as regards ex ante and ex post checks on declarations of interests, and will support the Executive Director in hits further efforts;
Amendment 6 #
Draft opinion
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Looks to the Agency to produce a report on the implementation of the system of ex ante and ex post verification of declarations of interests; shares the view of the Agency’s Executive Director that, given its scope, a system of that kind is beyond the Agency’s capacity and remit; believes, therefore, that one option to consider should be a legislative initiative whereby holders of a marketing authorisation (MA) for a pharmaceutical product would be obliged to publish agreements and all benefits in cash or in kind that they provided, directly or indirectly, to experts or bodies with whom they worked;